Variation in genomic landscape of clear cell renal cell carcinoma across Europe. - Wikidata - wikimedia - TriplyDB

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

http://www.wikidata.org/entity/Q51019551

about

Genomics of Cancer and a New Era for Cancer Prevention Cancer prevention as part of precision medicine: 'plenty to be done'Balkan endemic nephropathy: an update on its aetiology Aristolochic acid exposure in Romania and implications for renal cell carcinoma Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.Causality in cancer research: a journey through models in molecular epidemiology and their philosophical interpretation.Genome-wide association study identifies multiple risk loci for renal cell carcinoma.A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.Mutation signatures implicate aristolochic acid in bladder cancer development New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid.Omeprazole Alleviates Aristolochia manshuriensis Kom-Induced Acute Nephrotoxicity.Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid.Independent Tumor Origin in Two Cases of Synchronous Bilateral Clear Cell Renal Cell Carcinoma.Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells.Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma.Tumour and patient factors in renal cell carcinoma-towards personalized therapy.New advances in genitourinary cancer: evidence gathered in 2014.Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients.Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma.International cancer seminars: a focus on kidney cancer.Molecular profiling of renal cell carcinoma: building a bridge toward clinical impact.Precision medicine from the renal cancer genome.Aristolochic Acid in the Etiology of Renal Cell Carcinoma.GHSR hypermethylation: a promising pan-cancer marker.Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft models.Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.*K-means and cluster models for cancer signatures.Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy.DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer.Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-β-dependent and -independent mechanisms.Large-scale genome-wide screening of circulating microRNAs in clear cell renal cell carcinoma reveals specific signatures in late-stage disease.Consequences of VHL Loss on Global DNA Methylome.Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.Generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinoma.Global characterization of copy number variants in epilepsy patients from whole genome sequencing.Hypoxic marker CA IX and adhesion mediator β-catenin are downregulated by lymphocytic choriomeningitis virus persistent infection.

P2860

Q26779113-1EF900EC-24BC-49AB-8FBC-8B74D3C96AA7 Q26995183-3F2A352F-DAEB-4D1C-AAFA-D62FAD1DBA0B Q28079308-609DE98D-AC4D-41C4-841C-05BEBD346360 Q28602446-6FB35DBF-EBDD-4D4C-A9DA-C7505BA0A559 Q30249783-1B9C1052-5E46-4E10-BE75-A1C2759B9980 Q30402873-3E0CE09B-982A-4068-845E-FEB4B9582CA2 Q33804470-F959F72F-AC07-450D-AF43-3843A1713015 Q33869005-3A151818-3F14-44C1-91EF-EE4DD407C2AC Q35646186-A88EF567-0207-4F58-9333-07434F2BC82A Q36041371-680F9BC0-73EF-40F2-888A-85F74877AA5F Q36157755-B09C9E48-AD3C-481A-974D-9318ADB0093D Q36367103-24C7F6F5-D68D-4D2D-A603-CA48BC4254E6 Q36725046-D0020BB7-136B-46D2-B8C9-5ADD4B524672 Q37072963-9F33291E-5645-4B09-94D2-DA6AA606C79D Q37074055-A9454CB4-2B72-4C34-9534-BD42D7DA5231 Q37717383-A2373DF2-5B94-4607-AA66-A34CBD8B2B4A Q38418649-F88E5E4C-ABC4-43AC-B11F-9A7D4CE5669C Q38557894-CC7D2533-BD3B-4952-97A0-8AE8002DEAF3 Q38620814-0664F073-4A03-4EAA-B27C-315AD1154219 Q38655126-C4CE32AB-54D5-42D1-B87E-70943559B5C1 Q38873586-76DB3AA6-A6D2-43BE-A891-10F139CFAD8F Q38910995-C5DEA4AC-A7CF-4DC4-AF87-BC781ACF4860 Q38970282-FAFA64DF-2B4C-4431-AAB7-C9163991B76E Q39459925-91731201-B9C2-45C1-AEEA-59E0D273B7F4 Q40216663-98BEF32F-9F5D-4A16-97B4-B18126B1FB3E Q40243097-8CB554C6-EF00-4EE3-A1D6-79122829B179 Q41472778-1A36F1AE-2393-49B9-90BD-55F8B402833F Q41574276-CC250A20-C76E-4D6B-B597-8ECA4B382E19 Q42265689-74BA4FC9-E5DF-4D72-B360-31C9C68F713A Q45901125-D8EE579A-79EF-4F7C-9132-1839CB4F28CC Q47096788-27D8EC00-77D3-4833-AD38-84142EBC6BEF Q48120175-A7CA4475-1E77-4E86-B771-283EBFEA7C4A Q48238662-45D02CA5-41E4-4617-9F2F-09EED0E30305 Q49789775-E6245DFB-7989-48BD-A586-AE5D4E40CCBC Q52321029-EF005FDF-DF48-4588-B9FC-7451938EB086 Q52321032-EB98A250-9CCE-485D-BB48-5D3F8D312E90 Q52321041-2A1EFA05-5E25-4D85-BB57-3E30D722A0AF Q52590924-48F142D6-B16A-4B7D-831B-79A5C9E8A645 Q52591846-AC351034-19E3-4B86-B604-D8276BAC836D Q52645855-F4EFAC66-0B31-4D9A-A962-B8983E7AEB25

P2860

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

http://www.wikidata.org/entity/Q51019551

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

@en

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

@en-gb

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

@nl

type

label

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

@en

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

@en-gb

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

@nl

prefLabel

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

@en

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

@en-gb

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

@nl

P1433

Q51019551-5D7D5E03-015B-40D6-BC74-46FF6B63BB8B

P1476

Q51019551-F2147D6B-3388-4EE4-8D18-CABB92BCB83E

P2093

Q51019551-01A35E63-AE27-4B7D-A15A-6B99BD2EF20E

Q51019551-0757ACC7-5007-474E-9DF0-777935FDF41C

Q51019551-0B42DF49-C9AD-40C8-8A22-B67CC02F70A2

Q51019551-1374CAA0-A912-44CE-8839-A3E10ED35548

Q51019551-13DAED4B-C6C7-498A-BD14-36273E1A2E22

Q51019551-1811B724-7313-421A-828D-CCFD8D199E23

Q51019551-18DC2FB5-5839-4A10-B957-BEE49874FEC4

Q51019551-1B23670C-B44B-4A2D-8CA2-D758E1DBEE2A

Q51019551-1D008CA2-023B-40D8-93D7-9B0DA24C4065

Q51019551-23287023-18CF-4F3B-9A16-F8768DB25D83

P2860

Q51019551-010F0A4E-0402-44BC-A098-154C2A202477

Q51019551-0322636E-071E-4156-AEF1-93826933BEC7

Q51019551-05F7773E-C6B5-4EF9-A406-C8D30EE7BB73

Q51019551-0A0D01EC-FDD5-4E8B-8955-607191D34BD4

Q51019551-0C4F6434-8C51-458E-9715-9771E8D91852

Q51019551-10B660AC-8A8D-4ADC-BD70-96E475AE252F

Q51019551-11406B01-FC0A-437A-A054-AD3A063387AF

Q51019551-1474F05F-CC5F-43B1-B55D-9BB9125139AB

Q51019551-17C6FD58-522E-4AEA-BB1A-4F671103F4D4

Q51019551-1D82A723-2841-4421-8646-86B17342FDE5

P2888

Q51019551-2252842B-74C3-4584-B342-96E2712370C0

P304

Q51019551-6EEBC3D9-D7BE-4831-A91C-57F6EC9D6249

P31

Q51019551-73B027D4-96DB-4E92-8BA1-3FE21B7BB003

P356

Q51019551-0FBBF117-124A-4498-A947-76FFABD841F4

P407

Q51019551-550A2B43-D66B-46CE-B5E7-C1BCDB9574B6

P478

Q51019551-10D440BE-178B-44BE-86C7-F5C3DEC2AEC1

P50

Q51019551-06B024E9-6B89-45DD-B59D-13DEA1EB3916

Q51019551-20299283-75AF-4AEC-A2DF-DC2A9AF47444

Q51019551-2724D09D-2693-4D69-84CD-CE1DBF77892D

Q51019551-27C53309-99E2-46E3-91FD-E6C87EB95B14

Q51019551-33F5AAFC-BB84-4E30-A8C8-9EC8353D88DE

Q51019551-59A4C442-B8B5-405E-94E1-92D47F47BA23

Q51019551-5FF9F615-B4A1-4CD0-9DED-EB09908172F0

Q51019551-648EC223-D76F-48A4-8FA6-7E9CA1CE2072

Q51019551-69A61D2D-ACFE-45D6-9C39-6FB2C32E3004

Q51019551-825FB889-9A5C-4655-8F45-2C0C196BF8C0

P577

Q51019551-089A348B-5F1B-43D4-BAE2-8AAEDDBF55A6

P5875

Q51019551-A56D3E16-5FCF-42C6-9502-F1600D71C08A

P698

Q51019551-F91717DF-EC01-4D6A-BC4D-C05668F16585

P356

P1433

Nature Communications

P1476

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

@en

P2093

Alexander Mazur

http://www.w3.org/2001/XMLSchema#string

Alexandre How-Kit

http://www.w3.org/2001/XMLSchema#string

Andris Zarins

http://www.w3.org/2001/XMLSchema#string

Anne Cambon-Thomsen

http://www.w3.org/2001/XMLSchema#string

Antoine Daunay

http://www.w3.org/2001/XMLSchema#string

Anush Moukeria

http://www.w3.org/2001/XMLSchema#string

Artem Artemov

http://www.w3.org/2001/XMLSchema#string

Christine Carreira

http://www.w3.org/2001/XMLSchema#string

Doris Lechner

http://www.w3.org/2001/XMLSchema#string

Edgars Celms

http://www.w3.org/2001/XMLSchema#string

P2860

AceView: a comprehensive cDNA-supported gene and transcripts annotation

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

Matrix crosslinking forces tumor progression by enhancing integrin signaling

TopHat: discovering splice junctions with RNA-Seq

Aristolochic acid and the etiology of endemic (Balkan) nephropathy

Comprehensive molecular characterization of clear cell renal cell carcinoma.

Integrated molecular analysis of clear-cell renal cell carcinoma.

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

The Sequence Alignment/Map format and SAMtools

InterPro--an integrated documentation resource for protein families, domains and functional sites

P2888

P304

5135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS6135

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Ivana Holcátová

Lenka Foretová

Rosamonde Elizabeth Banks

Mehran Karimzadeh

Behnoush Abedi-Ardekani

P577

2014-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268524720

http://www.w3.org/2001/XMLSchema#string

P698

25351205

http://www.w3.org/2001/XMLSchema#string